PHARMACEUTICAL AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
摘要
<p>This invention relates to the use of certain 3-substituted 2-oxindole-1-carboxamides and their pharmaceutically acceptable base salts for the treatment or prevention of Alzheimer's disease in mammals, including humans.</p>
